Subscribe

EAPCI Column

DOI:

EAPCI Committees: a new way of working

The theme of the 2024-2026 EAPCI Presidency is #RISEANDLIFT with three key strategic driv- ers: inclusivity, transparency and meritocracy. For the election of the 2024-2026 EAPCI Board, voting was expanded to include voting for PCR representatives and the nominating committee positions, which historically were appointed.

With the expansion of voting and the presidential theme in mind, an open call for membership in the 2024-2026 EAPCI Committees was held. The aim of this open call was twofold: one, to match committee membership with the entire spectrum of EAPCI members, and two, to obtain a directory of the key areas of expertise of EAPCI members in order to broaden opportunities for participation in future EAPCI events. All interested EAPCI members were invited to complete an application form indicating the committee they preferred to serve on, as well as their motivation for participating in this committee.

The 2024-2026 EAPCI Committees have been expanded to include a new committee for educational content, courses and webinars. This committee will further develop EAPCI educational content online and develop focused educational modules which will be available onsite, online and in hybrid versions to target the needs of specific communities. The International Affairs and Partnerships Committee has separated from the National Society Committee to increase the cooperation with societies and groups outside EAPCI countries. The EAPCI Research, Digital and Innovation Committee has been divided into the EAPCI Scientific Research and Initiatives Committee and the EAPCI Digital and Innovation Committee to reflect the significant advances in both fields. Finally, a new committee dedicated to structural heart disease reflects the significant expansion of structural heart disease and transcatheter interventions.

The EAPCI open call for committee members was launched on 7 May 2024 and was extensively promoted via social media and the EAPCI newsletter and bulletin. Interactions with the National Society Presidents at the summer summit helped us to understand that, despite the previous work of the EAPCI Committees, not all members are present on social media and penetration of the EAPCI newsletter is still suboptimal. In an effort to resolve this, each National Society/ Working Group President has now received correspondence to distribute to their colleagues.

The call for members was extremely successful with 301 members applying for roles within the new committees, and each EAPCI member country is represented with Italy, Germany, and Poland leading the way. The EAPCI Young Committee, followed by the Structural Heart Disease and Scientific Documents Committee were the most popular committees. The high number of very qualified applicants lead to challenging discussions as to how to best complete each committee and, following approval from the EAPCI Executive Board, committee members will be publicly announced. Future EAPCI columns will focus on the important work of each committee.

Volume 20 Number 18
Sep 16, 2024
Volume 20 Number 18
View full issue

Suggested by Cory

Editorial

10.4244/EIJ-E-25-00022 Sep 15, 2025
An ongoing quest to discern the optimal antithrombotic therapy after TAVI
Hayashida K and Iwata J
free

Translational research

10.4244/EIJ-D-24-01000 Sep 15, 2025
DurAVR – a novel biomimetic balloon-expandable transcatheter valve for TAVI, valve-in-valve TAVI and redo-TAVI
Meier D et al
open access

Research Correspondence

10.4244/EIJ-D-25-00255 Sep 15, 2025
Redo-TAVI with the ACURATE platform for failure of short-frame transcatheter heart valves
Tarantini G et al

Original Research

10.4244/EIJ-D-24-01066 Sep 15, 2025
VARC-HBR criteria validation in TAVI patients on oral anticoagulation
Overduin D et al

Editorial

10.4244/EIJ-E-25-00038 Sep 15, 2025
Evolving cutoff values for optimising left main stenting with intravascular imaging
de la Torre Hernandez J
free

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free

Flashlight

10.4244/EIJ-D-25-00121 Sep 15, 2025
Calcium mapping by 3DStent technology
Amabile N and Benamer H
Trending articles
76.3

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
56.1

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
56.1

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
46.7

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
28.25

Clinical research

10.4244/EIJ-D-19-01006 Aug 7, 2020
Coronary collaterals and myocardial viability in patients with chronic total occlusions
Schumacher S et al
free
Chat with Cory
Hello , I'm Cory and I will do my best to answer your questions about this article. Please remember that this is an experimental feature, and that I'm still learning.
Can you provide a summary of the key findings in this article?
Can you extract and explain the primary hypothesis or research question addressed in this article?
What are the potential clinical applications or implications of the results presented in this paper?
How does this research contribute to our current understanding of cardiovascular disease management?
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved